{
    "2020-08-12": [
        [
            {
                "time": "2023-10-17",
                "original_text": "New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients",
                "features": {
                    "keywords": [
                        "Venetoclax",
                        "Phase 3",
                        "Positive Data",
                        "Acute Myeloid Leukemia",
                        "AML"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "Tweedy Browne Adds Morgan Stanley, AbbVie to Portfolio",
                "features": {
                    "keywords": [
                        "Tweedy Browne",
                        "Morgan Stanley",
                        "AbbVie",
                        "Portfolio Addition"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}